HK1207820A1 - Composition for manufacturing adjuvant for cancer patient receiving chemotherapy - Google Patents

Composition for manufacturing adjuvant for cancer patient receiving chemotherapy

Info

Publication number
HK1207820A1
HK1207820A1 HK15108440.2A HK15108440A HK1207820A1 HK 1207820 A1 HK1207820 A1 HK 1207820A1 HK 15108440 A HK15108440 A HK 15108440A HK 1207820 A1 HK1207820 A1 HK 1207820A1
Authority
HK
Hong Kong
Prior art keywords
composition
cancer patient
patient receiving
receiving chemotherapy
adjuvant
Prior art date
Application number
HK15108440.2A
Other languages
Chinese (zh)
Inventor
路孔明
Original Assignee
Microbio Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Microbio Co Ltd filed Critical Microbio Co Ltd
Publication of HK1207820A1 publication Critical patent/HK1207820A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/748—Cyanobacteria, i.e. blue-green bacteria or blue-green algae, e.g. spirulina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/02—Algae
    • A61K36/05—Chlorophycota or chlorophyta (green algae), e.g. Chlorella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/07—Basidiomycota, e.g. Cryptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/82—Theaceae (Tea family), e.g. camellia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/87—Vitaceae or Ampelidaceae (Vine or Grape family), e.g. wine grapes, muscadine or peppervine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/906—Zingiberaceae (Ginger family)
    • A61K36/9066—Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/308—Foods, ingredients or supplements having a functional effect on health having an effect on cancer prevention
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/10—Preparation or pretreatment of starting material
    • A61K2236/19—Preparation or pretreatment of starting material involving fermentation using yeast, bacteria or both; enzymatic treatment
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30—Extraction of the material
HK15108440.2A 2013-09-06 2015-08-31 Composition for manufacturing adjuvant for cancer patient receiving chemotherapy HK1207820A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TW102132310 2013-09-06

Publications (1)

Publication Number Publication Date
HK1207820A1 true HK1207820A1 (en) 2016-02-12

Family

ID=52701272

Family Applications (1)

Application Number Title Priority Date Filing Date
HK15108440.2A HK1207820A1 (en) 2013-09-06 2015-08-31 Composition for manufacturing adjuvant for cancer patient receiving chemotherapy

Country Status (5)

Country Link
JP (1) JP2015051970A (en)
KR (1) KR20150028754A (en)
CN (1) CN104415298A (en)
HK (1) HK1207820A1 (en)
TW (1) TWI673060B (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102646979B1 (en) * 2016-03-30 2024-03-13 마이크로바이오 컴퍼니 엘티디. Combined cancer therapy with immune checkpoint modulators and fermentation products by symbiotic microbiota
EP3254686A1 (en) * 2016-06-06 2017-12-13 Charsire Biotechnology Corp. Soybean seed extract, method for producing the same and uses thereof
US10543243B2 (en) 2016-06-06 2020-01-28 Charsire Biotechnology Corp. Soybeam seed extract, method for producing the same and uses thereof
CN107510813A (en) * 2016-06-15 2017-12-26 郭道明 Pharmaceutical composition for reducing side effects of cancer treatment drugs, preparation method and application thereof
TWI601535B (en) * 2016-06-23 2017-10-11 台灣利得生物科技股份有限公司 Use of compositions of water/alcohol extracts of antrodia cinnamomea cut-log cultivated fruiting body and solid-state cultivated mycelium as auxiliaries for anti-cancer agents
CN111655272A (en) * 2018-01-09 2020-09-11 中天生物科技股份有限公司 Method for activating Tumour Infiltrating Lymphocytes (TILs)
TWI658831B (en) * 2018-02-02 2019-05-11 神農真菌生技有限公司 Uses of Antrodia cinnamomea extract
CN109954053A (en) * 2019-04-23 2019-07-02 辽宁抗风竤生物医药科技有限责任公司 One kind having treatment breast cancer food therapeutic composition and preparation method thereof

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI252759B (en) * 2002-07-05 2006-04-11 Microbio Co Ltd Method of using fermented glycine max (L.) extract for enhancing natural killer cell activity
JP2005232032A (en) * 2004-02-17 2005-09-02 Kikkoman Corp Preventive and remedy for septicemia
JP2006022038A (en) * 2004-07-08 2006-01-26 Microbio Co Ltd Method for producing soybean fermentation extract
US20070082073A1 (en) * 2005-05-18 2007-04-12 University Of South Florida Catechin Adjuvants
TW200841883A (en) * 2007-04-20 2008-11-01 Microbio Company Ltd Taiwan Composition for prevention and/or treatment of cancer
EP2484367B1 (en) * 2009-09-28 2016-07-27 National University Corporation Tottori University Agent for preventing adverse side effects of carcinostatic agent
KR100992800B1 (en) * 2010-05-14 2010-11-08 주식회사 지씨에이치앤피 A process for preparing novel processed ginseng or extract thereof showing increased amount of minor ginsenosides
CN102145159B (en) * 2011-03-31 2012-08-29 青岛大学 Ginger and elecampane composition, preparation method of ginger and elecampane composition and use of ginger and elecampane composition for preparing toxicity-reducing efficacy-improving medicine in cancer radiotherapy and chemotherapy

Also Published As

Publication number Publication date
TWI673060B (en) 2019-10-01
KR20150028754A (en) 2015-03-16
JP2015051970A (en) 2015-03-19
TW201605461A (en) 2016-02-16
CN104415298A (en) 2015-03-18

Similar Documents

Publication Publication Date Title
HK1223552A1 (en) Combination therapies for cancer
EP3079707A4 (en) Immunotherapy of cancer
GB201322725D0 (en) Cancer therapy
HK1207820A1 (en) Composition for manufacturing adjuvant for cancer patient receiving chemotherapy
GB201321384D0 (en) Molecular adjuvant
GB201321242D0 (en) Immunogenic compound
HK1220900A1 (en) Cancer therapy
EP2956023A4 (en) Brassiere
EP2994148B8 (en) Cancer therapy
HK1219737A1 (en) Novel compounds for the treatment of cancer
IL240687A0 (en) Ganglioside compositions
EP3044593A4 (en) Cancer therapy
PL3053578T3 (en) Combination cancer therapy using azabicyclo compound
EP2961412A4 (en) Cancer therapy
PT3007725T (en) Beta-glycolipids for use as adjuvants
HK1213740A1 (en) Methods of making cancer compositions
PT2948129T (en) Therapeutic compounds
PL3016948T3 (en) 2-acylaminothiazoles for the treatment of cancer
EP3013332A4 (en) Cancer treatment
GB201320905D0 (en) Therapeutic compounds
GB201314286D0 (en) Therapeutic Compounds
GB201312499D0 (en) Therapeutic compounds
GB201317213D0 (en) Cancer Therapy
GB201321531D0 (en) Treatment for cancers
AP2015008905A0 (en) Novel compounds for the treatment of cancer